Literature DB >> 15013435

Primary structure and inducibility by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) of aryl hydrocarbon receptor repressor in a TCDD-sensitive and a TCDD-resistant rat strain.

Merja Korkalainen1, Jouko Tuomisto, Raimo Pohjanvirta.   

Abstract

The aryl hydrocarbon receptor repressor (AHRR) is a negative regulator of AH receptor (AHR), which mediates most of the toxic and biochemical effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). AHR has been shown to be the major reason for the exceptionally wide (ca. 1000-fold) sensitivity difference in acute toxicity of TCDD between two rat strains, sensitive Long-Evans (Turku/AB) (L-E) and resistant Han/Wistar (Kuopio) (H/W), but there is another, currently unknown contributing factor involved. In the present study, we examined AHRR structure and expression in these rat strains to find out whether AHRR could be this auxiliary factor. Molecular cloning of AHRR coding region showed that consistent with AHRR proteins in other species, the N-terminal end of rat AHRR is highly conserved, but PAS B and Q-rich domains are severely truncated or lacking. Identical structures were recorded in both strains. Next, the time-, dose-, and tissue-dependent expression of AHRR was determined using quantitative real-time RT-PCR. In liver, AHRR expression was very low in untreated rats, but it increased rapidly after TCDD exposure (100microg/kg). Testis exhibited the highest constitutive expression of AHRR, whereas kidney, spleen, and heart showed the highest induction of AHRR in response to TCDD treatment. Again, no marked differences were found between H/W and L-E rats, implying that AHRR is not the auxiliary contributing factor to the strain difference in TCDD sensitivity. However, simultaneous measurement of CYP1A1 mRNA reinforced the view that AHRR is an important determinant of tissue-specific responsiveness to TCDD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15013435     DOI: 10.1016/j.bbrc.2004.01.028

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

Review 1.  Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses.

Authors:  Laura N Vandenberg; Theo Colborn; Tyrone B Hayes; Jerrold J Heindel; David R Jacobs; Duk-Hee Lee; Toshi Shioda; Ana M Soto; Frederick S vom Saal; Wade V Welshons; R Thomas Zoeller; John Peterson Myers
Journal:  Endocr Rev       Date:  2012-03-14       Impact factor: 19.871

Review 2.  Regulation of constitutive and inducible AHR signaling: complex interactions involving the AHR repressor.

Authors:  Mark E Hahn; Lenka L Allan; David H Sherr
Journal:  Biochem Pharmacol       Date:  2008-09-20       Impact factor: 5.858

3.  Systematic evaluation of medium-throughput mRNA abundance platforms.

Authors:  Stephenie D Prokopec; John D Watson; Daryl M Waggott; Ashley B Smith; Alexander H Wu; Allan B Okey; Raimo Pohjanvirta; Paul C Boutros
Journal:  RNA       Date:  2012-11-20       Impact factor: 4.942

4.  Knockdown of a zebrafish aryl hydrocarbon receptor repressor (AHRRa) affects expression of genes related to photoreceptor development and hematopoiesis.

Authors:  Neelakanteswar Aluru; Matthew J Jenny; Mark E Hahn
Journal:  Toxicol Sci       Date:  2014-03-27       Impact factor: 4.849

5.  An aryl hydrocarbon receptor repressor from Xenopus laevis: function, expression, and role in dioxin responsiveness during frog development.

Authors:  Anna L Zimmermann; Elizabeth A King; Emelyne Dengler; Shana R Scogin; Wade H Powell
Journal:  Toxicol Sci       Date:  2008-04-02       Impact factor: 4.849

6.  The aryl hydrocarbon receptor repressor - More than a simple feedback inhibitor of AhR signaling: Clues for its role in inflammation and cancer.

Authors:  Christoph F A Vogel; Thomas Haarmann-Stemmann
Journal:  Curr Opin Toxicol       Date:  2017-03-01

7.  Induction of oxidative stress responses by dioxin and other ligands of the aryl hydrocarbon receptor.

Authors:  John F Reichard; Timothy P Dalton; Howard G Shertzer; Alvaro Puga
Journal:  Dose Response       Date:  2006-05-01       Impact factor: 2.658

Review 8.  A critique of the European Commission document, "State of the Art Assessment of Endocrine Disrupters".

Authors:  Lorenz R Rhomberg; Julie E Goodman; Warren G Foster; Christopher J Borgert; Glen Van Der Kraak
Journal:  Crit Rev Toxicol       Date:  2012-05-26       Impact factor: 5.635

9.  Gender differences in transcriptional signature of developing rat testes and ovaries following embryonic exposure to 2,3,7,8-TCDD.

Authors:  Solange Magre; Diane Rebourcet; Muhammad Ishaq; Richard Wargnier; Cyrille Debard; Emmanuelle Meugnier; Hubert Vidal; Joëlle Cohen-Tannoudji; Brigitte Le Magueresse-Battistoni
Journal:  PLoS One       Date:  2012-07-09       Impact factor: 3.240

10.  Growth of a human mammary tumor cell line is blocked by galangin, a naturally occurring bioflavonoid, and is accompanied by down-regulation of cyclins D3, E, and A.

Authors:  Tessa J Murray; Xinhai Yang; David H Sherr
Journal:  Breast Cancer Res       Date:  2006-03-27       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.